跳至主要内容
临床试验/NL-OMON53838
NL-OMON53838招募中不适用

Validation of an Intestinal Ultrasound Score Evaluating Inflammation and Treatment Response in Crohn*s Disease (USE-IT): A Prospective Multicenter Study. - USE-IT

International Bowel Ultrasound Group (IBUS)0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Confirmed diagnosis of CD according to standard clinical, endoscopic, and
  • histologic criteria of at least 3 months duration
  • 2. Adults 18 years of age or older
  • 3. Moderate to severely active CD defined by:
  • a. Active symptoms with an HBI score >= 5, and
  • b. Bowel wall inflammation defined as bowel wall thickness (BWT) > 3 mm in at
  • least 1 segment of the ileum or colon as determined by IUS
  • 4. Patients with planned introduction of an SOC biologic and/or JAK inhibitor
  • therapy approved for CD as per their treating gastroenterologist to treat
  • active disease
  • 5. Written informed consent must be obtained and documented

排除标准

  • 1. Patients with a primary diagnosis of ulcerative colitis or IBD type
  • unclassified
  • 2. Patients with prior intestinal surgery
  • 3. Disease-related structural bowel complications as defined by CONSTRICT
  • a. Localized luminal narrowing (luminal diameter reduction of at least 50%
  • relative to normal adjacent bowel loop), and
  • b. Bowel wall thickening (25% increase relative to adjacent unaffected bowel),
  • c. Either: maximum associated small bowel dilation (luminal diameter greater
  • than or equal to 3 cm) OR inability to pass an adult or pediatric colonoscope
  • through the narrowed area prior to dilation and unequivocal proximal small
  • bowel dilation (but may be less than 3 cm). Endoscopic diagnosis of stricture
  • should be within 6 months of MRE
  • 4. Disease-related penetrating complications (excluding perianal fistulizing
  • disease; patients with perianal disease are eligible if there is additional
  • inflammation in another bowel segment [other than the rectum])
  • 5. Contraindication to IC or MRE
  • 6. BMI greater than 35 at time of screening or other characteristics considered
  • likely to preclude IUS visualization of all bowel segments
  • 7. Disease limited to the rectum
  • 8. Serious underlying disease other than CD that in the opinion of the
  • investigator may interfere with the participant*s ability to participate fully
  • in the study
  • 9. History of alcohol or drug abuse that in the opinion of the investigator may
  • interfere with the participant*s ability to comply with the study procedures
  • 10. Pregnancy and female patients of child-bearing potential planning a
  • pregnancy during the study period

研究者

发起方
International Bowel Ultrasound Group (IBUS)

相似试验